Cellobiose

Cellobiose

SCHEMBL5054467

CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cellobiose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGALS3 P17931 3/20 0.53
LGALS8 O00214 2/20 0.53
LGALS4 P56470 2/20 0.53
IGF2R P11717 1/20 0.51
AMY2A P04746 3/20 0.51
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
AMY1A P0DUB6 2/20 0.47
LGALS9 O00182 1/20 0.46
LGALS1 P09382 1/20 0.46
LGALS7; LGALS7B P47929 1/20 0.46
SLC28A3 Q9HAS3 1/20 0.45
GAA P10253 4/20 0.45
MGAM O43451 2/20 0.45
SI P14410 1/20 0.45
CNR1 P21554 1/20 0.45
PTGS1 P23219 1/20 0.45
PDE4A P27815 1/20 0.45
PDE3A Q14432 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cellobiose SCHEMBL2304420 0.94 LGALS3 (0.53) LGALS3LGALS8LGALS4IGF2RAMY2A
Cellobiose SCHEMBL19951548 0.93 LGALS3 (0.54) LGALS3LGALS8LGALS4IGF2RAMY2A
Cellobiose SCHEMBL21924091 0.92 LGALS3 (0.49) LGALS3LGALS8LGALS4IGF2RAMY2A
Cellobiose SCHEMBL21924120 0.92 LGALS3 (0.49) LGALS3LGALS8LGALS4IGF2RAMY2A
Cellobiose SCHEMBL21924096 0.92 LGALS3 (0.49) LGALS3LGALS8LGALS4IGF2RAMY2A
Cellobiose SCHEMBL16346065 0.92 LGALS3 (0.51) LGALS3LGALS8LGALS4IGF2RAMY2A
Cellobiose SCHEMBL22774373 0.92 IGF2R (0.52) LGALS3LGALS8LGALS4IGF2RAMY2A
Cellobiose SCHEMBL28101430 0.91 LGALS3 (0.53) LGALS3LGALS8LGALS4IGF2RAMY2A
Maltotriose SCHEMBL28087482 0.91 LGALS3 (0.53) LGALS3LGALS8LGALS4IGF2RAMY2A
Maltotriose SCHEMBL28155902 0.91 LGALS3 (0.53) LGALS3LGALS8LGALS4IGF2RAMY2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993565-A2 NUTRACEUTICAL COMPOSITIONS FROM MICROALGAE AND RELATED METHODS OF PRODUCTION AND ADMINISTRATION Solazyme, Inc. (US) 2008-11-26 EP disclosed
WO-2007136428-A2 NUTRACEUTICAL COMPOSITIONS FROM MICROALGAE AND RELATED METHODS OF PRODUCTION AND ADMINISTRATION SOLAZYME, INC. (US) 2007-11-29 WO disclosed